References
- Leung B. P., Sattar N., Crilly A., Prach M., McCarey D. W., Payne H., et al. A novel anti‐inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003; 170: 1524–30
- McCarey D. W., McInnes I. B., Madhok R., Hampson R., Scherbakov O., Ford I., et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double‐blind, randomised placebo‐controlled trial. Lancet 2004; 363: 2015–21
- Kanda H., Hamasaki K., Kubo K., Tateishi S., Yonezumi A., Kanda Y., et al. Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis. J Rheumatol 2002; 29: 2024–6
- Abud‐Mendoza C., de la Fuente H., Cuevas‐Orta E., Baranda L., Cruz‐Rizo J., Gonzalez‐Amaro R. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Lupus 2003; 12: 607–11
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45
- van Gestel A. M., Prevoo M. L., van ‘t Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34–40
- Devaraj S., Chan E., Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4489–96
- Lubberts E. IL‐17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 2008; 41: 84–91
- Murphy C. A., Langrish C. L., Chen Y., Blumenschein W., McClanahan T., Kastelein R. A., et al. Divergent pro‐ and antiinflammatory roles for IL‐23 and IL‐12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951–7
- Kim H. R., Kim H. S., Park M. K., Cho M. L., Lee S. H., Kim H. Y. The clinical role of IL‐23p19 in patients with rheumatoid arthritis. Scand J Rheumatol 2007; 36: 259–64
- Zapolska‐Downar D., Siennicka A., Kaczmarczyk M., Kolodziej B., Naruszewicz M. Simvastatin modulates TNFalpha‐induced adhesion molecules expression in human endothelial cells. Life Sci 2004; 75: 1287–302
- Coward W. R., Marei A., Yang A., Vasa‐Nicotera M. M., Chow S. C. Statin‐induced proinflammatory response in mitogen‐activated peripheral blood mononuclear cells through the activation of caspase‐1 and IL‐18 secretion in monocytes. J Immunol 2006; 176: 5284–92
- Youssef S., Stuve O., Patarroyo J. C., Ruiz P. J., Radosevich J. L., Hur E. M., et al. The HMG‐CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420: 78–84
- Morita Y., Fukazawa T., Hirashima M., Kaga K., Kusaoi M., Morita T., et al. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production. Scand J Rheumatol 2006; 35: 268–72